174 related articles for article (PubMed ID: 20206017)
21. Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
Riccardo F; Arigoni M; Buson G; Zago E; Iezzi M; Longo D; Carrara M; Fiore A; Nuzzo S; Bicciato S; Nanni P; Landuzzi L; Cavallo F; Calogero R; Quaglino E
BMC Genomics; 2014; 15 Suppl 3(Suppl 3):S1. PubMed ID: 25077564
[TBL] [Abstract][Full Text] [Related]
22. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.
Feng M; Kong FM; Gross M; Fernando S; Hayman JA; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1228-34. PubMed ID: 19251094
[TBL] [Abstract][Full Text] [Related]
23. High-frequency jet ventilation for complete target immobilization and reduction of planning target volume in stereotactic high single-dose irradiation of stage I non-small cell lung cancer and lung metastases.
Fritz P; Kraus HJ; Mühlnickel W; Sassmann V; Hering W; Strauch K
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):136-42. PubMed ID: 19910142
[TBL] [Abstract][Full Text] [Related]
24. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment.
Kupelian PA; Ramsey C; Meeks SL; Willoughby TR; Forbes A; Wagner TH; Langen KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1024-8. PubMed ID: 16005575
[TBL] [Abstract][Full Text] [Related]
25. Computed tomographic-pathologic correlation of gross tumor volume and clinical target volume in non-small cell lung cancer: a pilot experience.
Chan R; He Y; Haque A; Zwischenberger J
Arch Pathol Lab Med; 2001 Nov; 125(11):1469-72. PubMed ID: 11698004
[TBL] [Abstract][Full Text] [Related]
26. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
Willner J; Baier K; Caragiani E; Tschammler A; Flentje M
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):382-9. PubMed ID: 11872283
[TBL] [Abstract][Full Text] [Related]
27. Dual-energy micro-CT functional imaging of primary lung cancer in mice using gold and iodine nanoparticle contrast agents: a validation study.
Ashton JR; Clark DP; Moding EJ; Ghaghada K; Kirsch DG; West JL; Badea CT
PLoS One; 2014; 9(2):e88129. PubMed ID: 24520351
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal assessment of lung cancer progression in the mouse using in vivo micro-CT imaging.
Namati E; Thiesse J; Sieren JC; Ross A; Hoffman EA; McLennan G
Med Phys; 2010 Sep; 37(9):4793-805. PubMed ID: 20964199
[TBL] [Abstract][Full Text] [Related]
29. The use of the Active Breathing Coordinator throughout radical non-small-cell lung cancer (NSCLC) radiotherapy.
Brock J; McNair HA; Panakis N; Symonds-Tayler R; Evans PM; Brada M
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):369-75. PubMed ID: 20800379
[TBL] [Abstract][Full Text] [Related]
30. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.
Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M
Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482
[TBL] [Abstract][Full Text] [Related]
31. Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
Faught AM; Yamamoto T; Castillo R; Castillo E; Zhang J; Miften M; Vinogradskiy Y
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):202-209. PubMed ID: 28816147
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of angiogenesis using micro-computed tomography in a xenograft mouse model of lung cancer.
Savai R; Langheinrich AC; Schermuly RT; Pullamsetti SS; Dumitrascu R; Traupe H; Rau WS; Seeger W; Grimminger F; Banat GA
Neoplasia; 2009 Jan; 11(1):48-56. PubMed ID: 19107231
[TBL] [Abstract][Full Text] [Related]
33. Prevention of lung cancer progression by bexarotene in mouse models.
Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
[TBL] [Abstract][Full Text] [Related]
34. Dynamic volume vs respiratory correlated 4DCT for motion assessment in radiation therapy simulation.
Coolens C; Bracken J; Driscoll B; Hope A; Jaffray D
Med Phys; 2012 May; 39(5):2669-81. PubMed ID: 22559637
[TBL] [Abstract][Full Text] [Related]
35. Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.
Askoxylakis V; Dinkel J; Eichinger M; Stieltjes B; Sommer G; Strauss LG; Dimitrakopoulou-Strauss A; Kopp-Schneider A; Haberkorn U; Huber PE; Bischof M; Debus J; Thieke C
Radiat Oncol; 2012 Sep; 7():157. PubMed ID: 22974533
[TBL] [Abstract][Full Text] [Related]
36. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
[TBL] [Abstract][Full Text] [Related]
37. Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.
Everitt S; Hicks RJ; Ball D; Kron T; Schneider-Kolsky M; Walter T; Binns D; Mac Manus M
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1098-104. PubMed ID: 19386444
[TBL] [Abstract][Full Text] [Related]
38. Genetic evolutionary staging of early non-small cell lung cancer: the P53 --> HER-2/NEU --> ras sequence.
Shackney SE; Smith CA; Pollice A; Levitt M; Magovern JA; Wiechmann RJ; Silverman J; Sweeney L; Landreneau RJ
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):259-67. PubMed ID: 10424999
[TBL] [Abstract][Full Text] [Related]
39. Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancer.
Meng X; Frey K; Matuszak M; Paul S; Ten Haken R; Yu J; Kong FM
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):145-51. PubMed ID: 24725697
[TBL] [Abstract][Full Text] [Related]
40. Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy.
Gunter T; Ali I; Matthiesen C; Machiorlatti M; Thompson D; Algan O
J Med Imaging Radiat Oncol; 2014; 58(3):384-91. PubMed ID: 24592817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
